FIELD: application of a strain of Akkermansia muciniphila.
SUBSTANCE: strain Akkermansia muciniphila SNUG-61027 is proposed with access number KCTC 13530BP to increase the secretion of GLP-1 hormone. Also, compositions for either suppressing appetite in a patient with reduced GLP-1 hormone or preventing or treating metabolic disorders associated with GLP-1 hormone are provided containing the specified strain or its culture solution as an active substance. Also, the application of the said strain is provided either to suppress appetite in a patient with reduced GLP-1 hormone or to prevent, treat or alleviate GLP-1 hormone related metabolic disorders.
EFFECT: invention provides weight reduction and regulation of glucose homeostasis, effectively influences the activity of brown fat and the ability to secrete appetite regulating hormone.
15 cl, 12 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN OF AKKERMANSIA MUCINIPHILA AND APPLICATION THEREOF | 2019 |
|
RU2777068C1 |
| PROTEINS WITH A DOUBLE FUNCTION AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2016 |
|
RU2741345C2 |
| FGF21 Fc FUNCTION PROTEIN, GLP-1 Fc FUNCTION PROTEIN AND COMBINED THERAPEUTIC AGENT INCLUDING THEM AND THEIR USE | 2020 |
|
RU2804335C2 |
| NEW MODIFIED IMMUNOGLOBULIN Fc-FRAGMENT FUNCTION PROTEIN AND ITS USE | 2020 |
|
RU2800919C2 |
| GIPR ANTIBODY AND ITS GLP-1 FUNCTION PROTEIN AS WELL AS PHARMACEUTICAL COMPOSITION BASED ON IT AND ITS USE | 2019 |
|
RU2800370C2 |
| BISPECIFIC PROTEIN | 2019 |
|
RU2784486C1 |
| MUCOADHESIVE MICROORGANISM | 2017 |
|
RU2762940C2 |
| MICROORGANISM PRODUCING PUTRESCINE OR ORNITHINE AND METHOD FOR PRODUCING PUTRESCINE OR ORNITHINE USING THIS MICROORGANISM | 2016 |
|
RU2759956C1 |
| GLP-2 PEPTIBODY FOR INTRODUCTION BEFORE, DURING OR AFTER SURGICAL INTERVENTION | 2018 |
|
RU2795594C2 |
| METHOD FOR OBTAINING BIFUNCTIONAL PROTEINS AND THEIR DERIVATIVES | 2018 |
|
RU2795970C2 |
